glp-1 obesity drug updates today news october 2025 Perspectives from employers on the costs and issues associated with covering GLP-1 agonists for weight loss What is the pipeline for

Abbreviations : TZD thiazolidinediones, SGLT2 sodium-dependent glucose transporters 2, DPP-4 dipeptidyl peptidase IV, : risk reduction, ?: controversial effects or limited evidence Hypoglycemic agents with clear anti-tumor effects Metformin Metformin is among the most widely prescribed oral hypoglycemic agents in clinical practice

EMERGING TRENDS AND POTENTIAL PRACTICE IMPLICATIONS Research on GLP-1 agonists suggests that these medications may be effective treatments for conditions beyond diabetes and obesity, suggesting a broad potential impact on health care

Navigate the healthcare industry Healthcare Brew covers pharmaceutical developments, health startups, the latest tech, and how it impacts hospitals and providers to keep administrators and providers informed

Amelioration of diabetes mellitus by modulation of GLP-1 via targeting alpha-glucosidase using Acacia tortilis polysaccharide in Streptozotocin-Nicotinamide induced diabetes in rats

A healthy gut microbiome with diversity produces short-chain fatty acids, causing GLP-1 release